Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 26.96% on an annualized basis producing an average annual return of 41.34%. Currently, Moderna has a market capitalization of $31.45 billion.
Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 5 years ago, it would be worth $546.76 today based on a price of $81.83 for MRNA at the time of writing.
Moderna's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.